Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mielcarek

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Advanced Drug Delivery Reviews|August 23, 2001
Nasal vaccination using live bacterial vectorsN Mielcarek, S Alonso, C Locht
Infection and Immunity|September 13, 2001
Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infectionS Alonso, K Pethe, N Mielcarek, et al.
Infection and Immunity|January 20, 2000
Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussisN Mielcarek, I Nordström, F D Menozzi, et al.
Infection and Immunity|May 12, 2001
Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infectionA George-Chandy, N Mielcarek, I Nordström, et al.
Journal of Bacteriology|February 1, 1996
Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutininG Renauld-Mongénie, J Cornette, N Mielcarek, et al.
Nature Biotechnology|May 21, 1998
Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussisN Mielcarek, G Riveau, F Remoué, et al.
Molecular Microbiology|January 1, 1996
Amino-terminal maturation of the Bordetella pertussis filamentous haemagglutininF Jacob-Dubuisson, C Buisine, N Mielcarek, et al.
Microbial Pathogenesis|May 1, 1997
Local transient induction of inflammatory cytokines after intranasal administration of recombinant Bordetella pertussisF Remoué, O Poulain-Godefroy, N Mielcarek, et al.
Cellular Microbiology|March 22, 2001
Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxinN Mielcarek, E H Hörnquist, B R Johansson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in miceJ B Sun, N Mielcarek, M Lakew, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Advanced Drug Delivery Reviews|August 23, 2001
Nasal vaccination using live bacterial vectorsN Mielcarek, S Alonso, C Locht
Infection and Immunity|September 13, 2001
Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infectionS Alonso, K Pethe, N Mielcarek, et al.
Infection and Immunity|January 20, 2000
Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussisN Mielcarek, I Nordström, F D Menozzi, et al.
Infection and Immunity|May 12, 2001
Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infectionA George-Chandy, N Mielcarek, I Nordström, et al.
Journal of Bacteriology|February 1, 1996
Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutininG Renauld-Mongénie, J Cornette, N Mielcarek, et al.
Nature Biotechnology|May 21, 1998
Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussisN Mielcarek, G Riveau, F Remoué, et al.
Molecular Microbiology|January 1, 1996
Amino-terminal maturation of the Bordetella pertussis filamentous haemagglutininF Jacob-Dubuisson, C Buisine, N Mielcarek, et al.
Microbial Pathogenesis|May 1, 1997
Local transient induction of inflammatory cytokines after intranasal administration of recombinant Bordetella pertussisF Remoué, O Poulain-Godefroy, N Mielcarek, et al.
Cellular Microbiology|March 22, 2001
Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxinN Mielcarek, E H Hörnquist, B R Johansson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in miceJ B Sun, N Mielcarek, M Lakew, et al.
Pageof 2